Skip to main content

Table 1 Characteristics of patients with and without DM who underwent H. pylori eradication therapy

From: Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients

Total (n = 965) Non-DM (n = 447) DM (n = 518) p
Mean age (range), years 60.7 (27–84) 64.8 (30–86) <0.0001*
Sex, n (%)    <0.0001*
 Female 139 (31.1 %) 97 (18.7 %)  
 Male 308 (68.9 %) 421 (81.3 %)  
Mean follow-up period (range), years 4.18 (0.54–13.2) 4.78 (0.68–16.2) 0.0006*
Mean endoscopy interval (range), years 1.37 (0.40–8.38) 1.61 (0.34–8.08) <0.0001*
Mean body mass index (range), kg/m2 23.1 (14.8–34.9) 23.4 (15.9–32.3) 0.1452
Atrophic gastritis grade, n (%)    0.0011*
 Mild 95 (21.3 %) 78 (15.1 %)  
 Moderate 207 (46.3 %) 215 (41.5 %)  
 Severe 145 (32.4 %) 225 (43.4 %)  
Hypertension, n (%) 99 (22.1 %) 244 (47.1 %) <0.0001*
Hyperlipidemia, n (%) 89 (19.9 %) 220 (42.5 %) <0.0001*
Hyperuricemia, n (%) 32 (7.16 %) 48 (9.27 %) 0.236
  1. DM diabetes mellitus
  2. *Statistically significant (p < 0.05)